Buy or sell Proof Diagnostics stock pre IPO via an EquityZen fund
EquityZen is a marketplace for shares of proven pre IPO tech companies

Proof Diagnostics Stock
Proof Diagnostics develops CRISPR‑based COVID‑19 molecular tests to help communities take control of their health.
About Proof Diagnostics Stock
Proof Diagnostics develops CRISPR‑based COVID‑19 molecular tests to help communities take control of their health.
Funding History
April 2022 | $45.0M |
---|
Management
Co-Founder
Feng Zhang
Co-Founder
Jonathan Gootenberg
Co-Founder
Omar Abudayyeh
Chief Operating Officer
Brian Mitchell
Co-Founder & CEO
Siddharth Shenai
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase